[A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)]

Rinsho Ketsueki. 2022;63(2):104-107. doi: 10.11406/rinketsu.63.104.
[Article in Japanese]

Abstract

Variants of the t (8;21) (q22;q22) involving chromosome 8, 21, and other chromosomes account for about 3% of all t (8;21) (q22;q22) in patients with acute myeloid leukemia (AML). However, the prognosis of AML with variant t (8;21) remains unknown due to the scarcity of reported cases. Herein we report a case of AML with t (6;21;8) (p23;q22;q22). Fluorescence in situ hybridization confirmed a RUNX1-RUNX1T1 fusion signal on the derivative chromosome 8. This is the first report on a variant of t (8;21) involving the breakpoint 6p23. After induction chemotherapy, our patient achieved complete remission and has been stable for four years.

Keywords: Acute myeloid leukemia; RUNX1/RUNX1T1; Three-way translocation.

Publication types

  • Case Reports

MeSH terms

  • Chromosomes, Human, Pair 21 / genetics
  • Chromosomes, Human, Pair 8* / genetics
  • Core Binding Factor Alpha 2 Subunit / genetics
  • Humans
  • In Situ Hybridization, Fluorescence
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / genetics
  • RUNX1 Translocation Partner 1 Protein / genetics
  • Translocation, Genetic

Substances

  • Core Binding Factor Alpha 2 Subunit
  • RUNX1 Translocation Partner 1 Protein
  • RUNX1 protein, human
  • RUNX1T1 protein, human